Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 2
1959 1
1964 2
1965 1
1966 4
1967 1
1968 2
1969 3
1970 2
1972 2
1973 3
1974 2
1975 3
1976 4
1977 3
1978 6
1979 7
1980 7
1981 5
1982 8
1983 4
1984 6
1985 2
1986 4
1987 8
1988 4
1989 6
1991 3
1992 4
1993 9
1994 9
1995 9
1996 8
1997 9
1998 11
1999 8
2000 3
2001 9
2002 10
2003 10
2004 17
2005 20
2006 21
2007 17
2008 29
2009 21
2010 26
2011 18
2012 23
2013 22
2014 14
2015 23
2016 27
2017 29
2018 26
2019 23
2020 32
2021 39
2022 43
2023 32
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

646 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial.
Stein Gold L, Papp K, Pariser D, Green L, Bhatia N, Sofen H, Albrecht L, Gooderham M, Chen M, Paris M, Wang Y, Callis Duffin K. Stein Gold L, et al. Among authors: paris m. J Am Acad Dermatol. 2022 Jan;86(1):77-85. doi: 10.1016/j.jaad.2021.07.040. Epub 2021 Jul 31. J Am Acad Dermatol. 2022. PMID: 34343599 Clinical Trial.
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial.
Mrowietz U, Barker J, Conrad C, Jullien D, Gisondi P, Flower A, Reddy J, Paris M, Picard H, Jardon S, Augustin M. Mrowietz U, et al. Among authors: paris m. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):348-355. doi: 10.1111/jdv.18689. Epub 2022 Nov 14. J Eur Acad Dermatol Venereol. 2023. PMID: 36300769 Clinical Trial.
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial.
Merola JF, Parish LC, Guenther L, Lynde C, Lacour JP, Staubach P, Cheng S, Paris M, Picard H, Deignan C, Jardon S, Chen M, Papp KA. Merola JF, et al. Among authors: paris m. J Am Acad Dermatol. 2024 Mar;90(3):485-493. doi: 10.1016/j.jaad.2023.10.020. Epub 2023 Oct 16. J Am Acad Dermatol. 2024. PMID: 37852306 Free article. Clinical Trial.
The crustacean model Parhyale hawaiensis.
Paris M, Wolff C, Patel NH, Averof M. Paris M, et al. Curr Top Dev Biol. 2022;147:199-230. doi: 10.1016/bs.ctdb.2022.02.001. Epub 2022 Mar 14. Curr Top Dev Biol. 2022. PMID: 35337450 Free article.
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study.
Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S, Tada Y, Abe M, Yaguchi M, Uehara N, Handa T, Tanaka M, Zhang W, Paris M, Murakami M. Terui T, et al. Among authors: paris m. Am J Clin Dermatol. 2023 Sep;24(5):837-847. doi: 10.1007/s40257-023-00788-2. Epub 2023 May 26. Am J Clin Dermatol. 2023. PMID: 37233897 Free PMC article. Clinical Trial.
646 results